Zevra Therapeutics Inc (ZVRA)
9.585
+0.46
(+4.98%)
USD |
NASDAQ |
Nov 22, 16:00
9.64
+0.06
(+0.57%)
After-Hours: 20:00
Zevra Therapeutics Revenue (Annual): 27.46M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 27.46M |
December 31, 2022 | 10.16M |
December 31, 2021 | 28.65M |
Date | Value |
---|---|
December 31, 2020 | 13.29M |
December 31, 2019 | 12.84M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
10.16M
Minimum
2022
28.65M
Maximum
2021
18.48M
Average
13.29M
Median
2020
Revenue (Annual) Benchmarks
Johnson & Johnson | 85.16B |
Ionis Pharmaceuticals Inc | 787.65M |
Vanda Pharmaceuticals Inc | 192.64M |
BioCardia Inc | 0.477M |
Xeris Biopharma Holdings Inc | 163.91M |